N

NanoEnTek Inc
KOSDAQ:039860

Watchlist Manager
NanoEnTek Inc
KOSDAQ:039860
Watchlist
Price: 5 360 KRW -14.38%
Market Cap: ₩204.2B

NanoEnTek Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

NanoEnTek Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
N
NanoEnTek Inc
KOSDAQ:039860
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Research & Development
-₩173.8B
CAGR 3-Years
N/A
CAGR 5-Years
-176%
CAGR 10-Years
N/A
A
ADM Korea Inc
KOSDAQ:187660
Research & Development
-₩10.7B
CAGR 3-Years
-158%
CAGR 5-Years
-74%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Research & Development
-₩15.8B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-24%
S
ST Pharm Co Ltd
KOSDAQ:237690
Research & Development
-₩20.9B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Research & Development
-₩171.1B
CAGR 3-Years
-72%
CAGR 5-Years
-51%
CAGR 10-Years
-36%
No Stocks Found

NanoEnTek Inc
Glance View

NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
2 742.14 KRW
Overvaluation 49%
Intrinsic Value
Price
N

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett